Categories: DesignEngineeringPlatform
Custom-engineered radiotherapies to attack cancer in bold new ways
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 24.04.2023 | Abdera Therapeutics Raises $142M in Series A And Series B Funding | Abdera Therapeutics, a Menlo Park, CA and Vancouver, Canada-based biopharmaceutical company that provides an antibody engineering ROVEr platform, raised $142M in Series A and Series B funding.
Versant Ventures and Amplitude Ventures led the... |
| - | 🏙️ $142 million for biotech venture Abdera Therapeutics | Happy Friday!! Welcome to the Morning Report. If someone else sent you this, you can subscribe right here, right now:
Subscribe
Vancouver’s Abdera Therapeutics has announced a total of $142 million in a combined Series A and B financing rou... |
Reviews 0
